Adare BIOME: DSM agrees to acquire postbiotics pioneer Adare Biome for US$301m

US - Royal DSM, a global science-based leader in health, nutrition and bioscience, has started acquisition talks with Adare Pharma Solutions to buy Adare Biome, a pioneer in the development and manufacturing of postbiotics, for an enterprise value of US$301.2 million. DSM anticipates the rapid extension of the availability of Adare Biome's Lactéol for people...